Grantham, Mayo, Van Otterloo & Co (GMO)’s Hess HES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-225,455
Closed -$31.2M 629
2025
Q2
$31.2M Sell
225,455
-79,571
-26% -$10.7M 0.09% 118
2025
Q1
$48.7M Sell
305,026
-102,592
-25% -$15.1M 0.15% 69
2024
Q4
$54.2M Buy
407,618
+22,546
+6% +$3.15M 0.18% 55
2024
Q3
$52.3M Buy
385,072
+76,341
+25% +$10.6M 0.16% 78
2024
Q2
$45.5M Buy
308,731
+217,953
+240% +$33.4M 0.15% 84
2024
Q1
$13.9M Sell
90,778
-164,578
-64% -$23.9M 0.05% 229
2023
Q4
$36.8M Sell
255,356
-304,782
-54% -$44.7M 0.16% 110
2023
Q3
$85.7M Sell
560,138
-98,228
-15% -$14.8M 0.4% 48
2023
Q2
$89.5M Sell
658,366
-58,400
-8% -$7.99M 0.41% 45
2023
Q1
$94.9M Buy
716,766
+289,046
+68% +$40.2M 0.48% 45
2022
Q4
$60.7M Sell
427,720
-283,981
-40% -$39M 0.32% 58
2022
Q3
$77.6M Sell
711,701
-100,200
-12% -$11.1M 0.45% 49
2022
Q2
$86M Buy
811,901
+646,455
+391% +$73.1M 0.47% 43
2022
Q1
$17.7M Buy
+165,446
New +$15.7M 0.09% 193
2021
Q4
Sell
-9,700
Closed -$758K 699
2021
Q3
$758K Buy
9,700
+4,200
+76% +$309K ﹤0.01% 555
2021
Q2
$480K Buy
+5,500
New +$444K ﹤0.01% 624
2017
Q4
Sell
-12,700
Closed -$596K 602
2017
Q3
$596K Buy
+12,700
New +$537K ﹤0.01% 410
2016
Q1
Sell
-23,043
Closed -$1.12M 596
2015
Q4
$1.12M Sell
23,043
-500
-2% -$28.4K ﹤0.01% 387
2015
Q3
$1.18M Sell
23,543
-73,200
-76% -$4.19M ﹤0.01% 392
2015
Q2
$6.47M Sell
96,743
-5,766
-6% -$409K 0.02% 225
2015
Q1
$6.96M Sell
102,509
-12,200
-11% -$870K 0.02% 233
2014
Q4
$8.47M Sell
114,709
-157,700
-58% -$12.5M 0.02% 206
2014
Q3
$25.7M Sell
272,409
-206,600
-43% -$20.4M 0.07% 129
2014
Q2
$47.4M Buy
479,009
+269,500
+129% +$24.3M 0.13% 93
2014
Q1
$17.4M Buy
209,509
+124,661
+147% +$9.91M 0.05% 162
2013
Q4
$7.04M Sell
84,848
-2,901
-3% -$236K 0.02% 254
2013
Q3
$6.79M Buy
87,749
+39,485
+82% +$2.94M 0.02% 255
2013
Q2
$3.21M Buy
+48,264
New +$3.34M 0.01% 358

Other funds holding HES

Grantham, Mayo, Van Otterloo & Co (GMO)'s HES Position: Q3 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Hess (HES) in Q3 2025, closing a stake of 225,455 shares — an estimated $31.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HES in Q2 2013 and held it in 28 quarters. The position peaked at $94.9M in Q1 2023. 7 funds tracked by Wall St. Rank hold HES as of Q3 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Hess position as of Q3 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 225,455 Hess shares in Q3 2025, an estimated $31.2M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Hess in Q2 2013 and held it in 28 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Hess position peaked at $94.9M in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Hess as of Q3 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.